Trademark: INNOPEUTICS 2033711
Word
INNOPEUTICS
Device Descrption:
HEXAGON,DIVIDED
ID
2033711
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
31 May 2019
Registration Date
12 August 2019
Renewal Date
31 May 2029
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases.
Pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases.